It is all about risk-adapted algorithms

Critical Care Medicine

Volumn 41, Issue 3, 2013, Pages

  Schuetz, Philipp ^a   Mueller, Beat ^a  

^a Medical University Department   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ALGORITHM; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; LETTER; MORTALITY; PATIENT MONITORING; PATIENT SAFETY; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK REDUCTION; SEPSIS;

ANTI-BACTERIAL AGENTS; CALCITONIN; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; PROTEIN PRECURSORS;

EID: 84874872243     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318275cdad     Document Type: Letter

References (8)

1. Schuetz P, Muller B, Christ-Crain M, et al.: Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012; 9:CD007498
2. Schuetz P, Chiappa V, Briel M, et al.: Procalcitonin algorithms for antibiotic therapy decisions: A systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011; 171:1322-1331
3. Burkhardt O, Ewig S, Haagen U, et al.: Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010; 36:601-607
4. Briel M, Schuetz P, Mueller B, et al.: Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008; 168:2000-2007; discussion 2007-2008
5. Bouadma L, Luyt CE, Tubach F, et al; PRORATA Trial Group: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010; 375:463-474
6. Schuetz P, Christ-Crain M, Thomann R, et al; ProHOSP Study Group: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The ProHOSP randomized controlled trial. JAMA 2009; 302:1059-1066
7. Layios N, Lambermont B, Canivet JL, et al.: Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 2012; 40:2304-2309
8. Hochreiter M, Köhler T, Schweiger AM, et al.: Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial. Crit Care 2009; 13:R83